Dense Breasts and Risk Scores: Which Screening Lane Are You In?
Part 1 of our Breast Cancer Awareness Month series
Pink ribbons, and a whole lot of letters
It's October, which means pink ribbons on everything from yogurt lids to football cleats to hockey rinks, and a cheerful chorus of "Don't forget your mammogram!" Great advice. Truly.
So you go. You get squished. A few days later, your provider's office sends the good news: "Your mammogram is normal." Happy dance. Portal closed. Back to real life.
That message is true, and it's great news. But when did you last read past the word "normal"? Your report also lists your breast density, a letter from A to D, and may say your tissue is dense. "Normal" means no cancer was seen today. Density tells you how well a mammogram can see in the first place. And your letter probably also told you to talk with your provider about it.
Wait. Talk about what, exactly? Is something wrong? Do you need more tests? And why does your friend get an MRI every year while you've only ever had mammograms?
If breast screening has started to feel like a bowl of alphabet soup (BI-RADS, ABUS, CEM, MRI, Tyrer-Cuzick, and a few more for good measure), you are not imagining it. Even clinicians debate this stuff over coffee. So grab a warm mug, and let's untangle it together.
Here's the big idea to hold onto: your screening plan depends on two separate questions.
How dense is your breast tissue?
What is your overall lifetime risk of breast cancer?
They're related, but they are not the same thing, and they lead to different plans. This post helps you figure out which screening lane you're in. Part 2 covers the extra tests themselves, and the always-thrilling topic of who pays for them.
Why your mammogram report suddenly has opinions about your breast density
Since September 10, 2024, every mammography facility in the United States has been required to tell you whether your breast tissue is dense. This came from an FDA update to the Mammography Quality Standards Act, finalized in March 2023 after years of patient advocacy (FDA).
Before that, whether you heard about your density depended on which state you lived in, and the wording was all over the map. Now your radiologist assigns one of four density categories, and your results letter has to say whether your tissue is dense or not dense. Either way, the letter nudges you to talk with your provider about density, breast cancer risk, and your individual situation.
That nudge is a good thing. But notice what the letter politely leaves out: what you're actually supposed to do next. That part is up to you and your provider, and it depends on more than density alone.
So what is breast density, anyway?
Breast density describes how much of your breast is made of fibrous and glandular tissue compared with fatty tissue. You can't feel it, and it has nothing to do with breast size or firmness. Only a mammogram can see it.
Radiologists sort density into four letter categories using a system called BI-RADS (ACR BI-RADS Atlas):
| Category | What it means | Roughly how common | Counts as "dense?" |
| A | Almost entirely fatty | About 10% of women | No |
| B | Scattered areas of dense tissue | About 40% | No |
| C | Heterogeneously dense; may hide small masses | About 40% | Yes |
| D | Extremely dense; lowers mammogram sensitivity | About 10% | Yes |
So about half of all women have dense breasts. You're in very good company. Density often decreases with age and menopause, but not for everyone, and hormone therapy can nudge it back up.
Density matters for two reasons:
It can hide cancer. Dense tissue and tumors both show up white on a mammogram. Picture trying to spot a snowball in a snowstorm. Mammogram sensitivity is roughly 80 to 90% in non-dense breasts and can drop to around 60 to 70% in dense breasts.
It modestly raises risk. Compared with average density, heterogeneously dense tissue carries about a 20% higher relative risk, and extremely dense tissue about twice the risk. That's a real bump, but on its own it usually doesn't put a woman in the "high risk" group. Which brings us to the lanes.
Lane 1: Average risk. A mammogram every year, starting at 40
Most women are at average risk, meaning a lifetime risk of breast cancer under 15% (the general population average is about 13%, or 1 in 8). For you, the plan is refreshingly simple: a screening mammogram every year, starting at age 40. That's what breast imaging specialists recommend, including the American College of Radiology and the Society of Breast Imaging (2023), and it's the standard we follow at Illumination Women's Health (ACR press release; ACR/SBI guidance summary).
Why every year? Cancers can grow in the space between screenings, and they tend to grow faster in younger women. National modeling studies estimate that yearly screening from 40 to 74 lowers breast cancer deaths by about 35%, compared with about 28% for screening every other year (coverage of the modeling). The trade-off is a few more callbacks for extra pictures, most of which turn out to be nothing. We think that's a trade worth making.
There's also no automatic stopping age. If you're healthy and would want treatment if cancer were found, screening generally continues.
That yearly mammogram is your foundation. If your breasts are dense (category C or D), you may want to build on top of it with a supplemental test. That's exactly what Part 2 is all about.
Meet your Tyrer-Cuzick breast cancer risk score (it's less scary than it sounds)
Here's where the second question comes in. "High risk" isn't about your mammogram alone. It's about your whole story: family history, genetics, hormones, biopsies, and more. To put a number on it, we use a risk calculator, and the one many breast specialists prefer has a name that sounds like a law firm: the Tyrer-Cuzick model (also called IBIS).
Tyrer-Cuzick asks about your age, body mass index, age at your first period and at menopause, pregnancies, hormone therapy use, prior breast biopsies, Ashkenazi Jewish ancestry, and detailed family history of breast and ovarian cancer on both sides of your family (overview). Yes, Dad's side counts too. The current version also includes breast density, which is where our two questions finally meet.
How to calculate your own score (yes, from your couch)
Good news: this is one piece of homework you can do yourself. Appointments go by fast, and walking in with your number already in hand makes the conversation with any provider quicker and more productive. The Tyrer-Cuzick calculator (IBIS version 8) is free online, and it takes about 10 minutes: https://magview.com/ibis-risk-calculator/. Think of it as a personality quiz, except the results are actually useful.
Before you start, gather:
Your age, height, and weight
Your age at your first period, and at menopause if you've gone through it
Your pregnancy history, including your age at your first birth
Whether you've used hormone therapy
Any breast biopsies and what they showed (your records will say)
Your breast density letter (A, B, C, or D) from your last mammogram report
Your family history on both sides: which relatives had breast or ovarian cancer, and at what age
Ashkenazi Jewish ancestry, and any genetic testing results in your family
Then:
Screenshot or print your results. You'll get two numbers: a 10-year risk and a lifetime risk.
If you weren't sure about an answer, make your best guess and jot down which ones you guessed on.
Bring your results to your next visit with your primary care provider, gynecologist, or breast specialist.
A few ground rules:
Your score is a starting point, not a verdict. If your lifetime risk comes back at 15% or higher, or you've had a biopsy showing atypia, share your results with your primary care provider, gynecologist, or breast specialist. They'll want to double-check your answers before anything like an MRI is ordered, because one small entry mistake can swing the number.
Skip the calculator if you've already had breast cancer or you carry a known gene mutation like BRCA1 or BRCA2. Your screening plan is based on that history instead, so talk with your care team about the right plan for you.
What your 10-year and lifetime risk numbers mean
The calculator gives you two numbers (IBIS v8 calculator FAQ):
10-year risk: your estimated chance of developing breast cancer over the next 10 years.
Lifetime risk: your estimated chance over the rest of your life. This is the number that drives screening decisions.
A lifetime risk of 22% means that out of 100 women with a profile like yours, about 22 would be expected to develop breast cancer during their lifetime, and about 78 would not. It's a probability, not a prophecy, and definitely not a diagnosis.
Here's how the lifetime number is generally sorted (Canadian Association of Radiologists Journal, 2024):
| Lifetime risk | Risk group | What it usually means for screening |
| Under 15% | Average | Yearly mammogram from 40, plus supplemental screening if breasts are dense |
| 15% to 20% | Intermediate | Yearly mammogram, and a closer conversation about supplemental screening, especially with dense breasts or atypia on a prior biopsy |
| 20% or higher | High | Yearly mammogram plus yearly MRI, often starting before 40 |
That middle group is honestly the trickiest, and guidelines vary on what to offer. Breast surgeons describe it as the most challenging group to advise (UPMC). This is where a real conversation with your provider matters most.
A few things worth knowing
Density can tip the scales. Because the current version includes density, the same woman can get a higher score once her density is entered. Sometimes density is the thing that bumps someone from intermediate to high risk.
Your score can change. A new cancer diagnosis in a relative, a biopsy result, a change in density, or simply another birthday can all shift your numbers. We recommend recalculating whenever your history changes.
No model is perfect. Tyrer-Cuzick can overestimate risk in women who've had atypical hyperplasia on a biopsy; one Mayo Clinic study found it predicted about 59 cancers over 10 years in a group where 31 actually occurred (Boughey et al., J Clin Oncol 2010). It also isn't designed for women who've already had breast cancer (IBIS calculator), and women with a known gene mutation like BRCA1 or BRCA2 follow gene-specific plans instead.
The American College of Radiology recommends that every woman have a breast cancer risk assessment by age 25, especially Black women and women of Ashkenazi Jewish heritage (ACR recommendations). The goal is simple: spot higher risk early enough to make a difference.
Lane 2: High risk (20% or more). Welcome to the twice-a-year club
If your calculated lifetime risk is 20% or higher, your screening steps up in a big way. The American College of Radiology (2023) recommends (ACR press release):
A yearly breast MRI, typically starting between ages 25 and 30
A yearly mammogram, starting somewhere between ages 25 and 40, depending on the type of risk
The National Comprehensive Cancer Network uses the same 20% threshold for risk models based largely on family history, and names Tyrer-Cuzick as one of them (MD Anderson screening algorithm, based on NCCN). One fun fact: the Gail model, another common calculator, isn't designed for deciding who qualifies for screening MRI.
Many practices stagger the two tests about six months apart: mammogram in, say, January and MRI in July. That way, someone is taking a careful look at your breasts twice a year instead of once. Doing both on the same day is also acceptable, and some women love the one-and-done convenience (MD Anderson algorithm).
High-risk care is about more than pictures. It may also include a referral for genetic counseling, a conversation about risk-reducing medications, and a clinical breast exam every 6 to 12 months. Your plan should fit you, not a template.
Find your lane (your screenshot-worthy cheat sheet)
Breast cancer found early is usually smaller, easier to treat, and more survivable. Dense tissue can hide cancer, and a high risk score means cancer is more likely to show up. When women don't know either piece of information, cancers can grow quietly between "normal" mammograms. Knowing your density and your risk turns a generic plan into one built for you.
| Your situation | Your foundation | Consider adding |
| Average risk, not dense (A or B) | Yearly mammogram starting at 40 | Nothing extra for most women |
| Average risk, dense (C) | Yearly mammogram starting at 40 | A conversation about supplemental screening (see Part 2) |
| Average risk, extremely dense (D) | Yearly mammogram starting at 40 | Supplemental screening, ideally a contrast-based test (see Part 2) |
| Intermediate risk (15% to 20%) | Yearly mammogram starting at 40 | An individualized supplemental screening conversation |
| High risk (20% or more) | Yearly mammogram, often starting before 40 | Yearly MRI, often staggered 6 months apart; genetics and prevention conversation |
Your homework (the easy kind):
Find your density letter (A, B, C, or D) on your last mammogram report.
Gather your family history on both sides: who had breast, ovarian, or other cancers, and at what age.
Calculate your lifetime risk with the free online Tyrer-Cuzick calculator, and bring a screenshot of your results to your next visit.
Book your yearly mammogram, if you haven't already. October is a great excuse.
Whether you see your primary care provider, a gynecologist, or us, this is a team effort. Bring your density letter and your risk score to the conversation. At Illumination Women's Health in Boise, we're always happy to review them with you and map out a plan, so you leave feeling informed instead of overwhelmed. When you're ready, you can schedule a visit online.
Coming up in Part 2: MRI, CEM, ABUS, oh my. We'll break down the supplemental tests for dense breasts, explain why extremely dense tissue changes which test makes the most sense, and tackle the true final boss: insurance. In the meantime, if insurance already has you scratching your head, our guide to understanding your insurance benefits is a good place to start.
Frequently asked questions about dense breasts and breast cancer risk
-
It means your radiologist placed your breast tissue in category C (heterogeneously dense) or D (extremely dense), so it contains more fibrous and glandular tissue than fat. It isn't a diagnosis, and about half of all women have dense breasts. It matters because dense tissue can hide cancer on a mammogram and modestly raises breast cancer risk.
-
Not automatically. Density on its own usually doesn't put a woman in the high-risk group that gets a yearly MRI. If your breasts are dense, a supplemental test on top of your yearly mammogram may make sense, ideally a contrast-based test if your tissue is extremely dense. Part 2 breaks down those options.
-
It's a breast cancer risk estimate from the Tyrer-Cuzick (IBIS) model. It looks at your age, body mass index, reproductive and hormone history, prior breast biopsies, family history on both sides, Ashkenazi Jewish ancestry, and breast density. It then gives you a 10-year risk and a lifetime risk. The free online calculator takes about 10 minutes.
-
A lifetime risk of 20% or higher is generally considered high. Between 15% and 20% is intermediate, and under 15% is average. For comparison, the general population average is about 13%, or 1 in 8.
-
If you're at average risk, we follow the American College of Radiology recommendation: a screening mammogram every year starting at age 40. Women at high risk often start earlier, and yearly MRI typically begins between ages 25 and 30.
-
It can. Density often decreases with age and menopause, but hormone therapy can nudge it back up. That's one more good reason to know your density letter and talk it through with your provider.
This post is for general education and isn't a substitute for personal medical advice. Talk with your provider about what's right for you.
Keep reading
Menopause Mystery Series - Hormone Therapy is Dangerous: what newer research says about hormone therapy safety
Understanding Your Insurance Benefits: what to check when your plan resets, and how we can help
